[Zhenggu Wan's bone-induced fusion mechanism is based on the BMP-2/Smad1/Runx2/Osterix signal pathwa

An international medical study has revealed new findings that have important reference value for the CDC. The purpose of this study is to explore the mechanism of osteoporosis-promoting GW and its regulatory role in the regulation of bone-forming protein-2 (βMP-2)/recombinant Smad 1 protein (Smad1)/runt-related transcription factor 2 (Runx2)/osteoblast-specific transcription factor (Osterix) signaling pathway). Xianling Gubao Capsule group (315 mg) and BMP specific inhibitor (noggin and ZGW) were studied within 28 days.

UMR-106 Bone marrow osteoblasts were treated with ZGW-containing serum and ZGW-containing serum and BMP-specific inhibitornoggin. The serum of mice detected the levels of bone metabolic marker BGP, type 2 tetrahydrocannabinol (PINP), bone absorption marker CTX-1 and type 2 tetrahydrocannabinol (NTX-1). The experiment used an enzyme-linked immunosuppression test ELISA.

The expression of BGP and OPN in post-skeletal tissues was evaluated by serum methamphetamine and erythropoietin (HE) chromosomes. The subjects included BGP and OPN in post-skeletal tissues, as well as UMR-106 cells. The evaluation process tested the expression levels of proteins in Western blot to determine the expression levels of BGP and OPN in post-skeletal tissues.

The results showed that the contents of CTX-1 and NTX-1 were significantly reduced and the contents of CTX-1 and NTX-1 were significantly elevated compared to the contents of BGP and PINP in the pig serum in the model group. The pathological results showed that the bone marrow at the end of the skeletal tissue was sparse, thin, irregularly arranged, while the protein expression of BGP, OPN, BMP-2, SMAD, Runx2 and Osterix in the tissues and cells was significantly reduced. Following ZW intervention, the contents of BGPPINP in the serum increased significantly.

The bone marrow transforms into more compact bone more quickly, and bone expression increases significantly in BGP, OPN, BMP-2, Smad1, Runx2, and Osterix in tissues and cells. In summary, ZGW can improve the pathway of BMP-2/Smad1/Runx2/Osterix signaling by upgrading the pathway of BMP-2/Smad1/Runx2/Osterix signaling, promoting bone healing and improving bone metabolism, thereby upgrading the pathway of BMP-2/Smad1/Runx2/Osterix signaling. It should be pointed out that the above content is based on international public research findings, for reference in HealthCop, and does not constitute clinical advice.

If you have any health questions, please consult professional medical personnel.